Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Prøve for å øke FEP-deltakelsen

1. oktober 2026 oppdatert av: William Smith, University of Pennsylvania

Økonomiske insentiver for å øke behandlingsdeltakelsen i førsteepisode psykosepleie: En ikke-randomisert, adaptiv pilotstudie

Individuals with first-episode psychosis (FEP) are at high-risk for several poor functional and clinical outcomes, including suicide. Coordinated Specialty Care (CSC) is a multidisciplinary, team-based intervention known to improve such outcomes, including suicide risk. However, 30-50% of patients disengage from CSC, thereby limiting its impact. This pilot study will develop and test feasibility of a behavioral change program that uses moderate financial incentives to encourage treatment engagement in 2 CSC programs. A single-arm of 80 patient-participants at these two clinics will be recruited to assess feasibility and acceptability from patient perspectives. Additionally,15 clinicians at these two clinics will be recruited to assess feasibility and acceptability from clinician perspectives, and 50 clinicians from peer clinics not involved in the intervention will be recruited to assess scalability of the intervention. The trial will feature an three-month period for recruitment and baseline data collection and will subsequently feature three intervention periods (3 months each) where modifications to the interventions will be tested (each informed by the feasibility and acceptability findings of the prior period) with the aim of sequentially improving it.

Studieoversikt

Status

Aktiv, ikke rekrutterende

Forhold

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Antatt)

145

Fase

  • Tidlig fase 1

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • North Carolina
      • Raleigh, North Carolina, Forente stater, 27608
        • University of North Carolina at Chapel Hill (ENCOMPASS Program)
    • Pennsylvania
      • Philadelphia, Pennsylvania, Forente stater, 19123
        • PEACE Program, Horizon House, Inc.
      • Philadephia, Pennsylvania, Forente stater, 19104
        • University of Pennsylvania

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  1. For all participants, age ≥ 18 years old.
  2. For intervention trial and patient feasibility and acceptability measurement: Patients with first-episode psychosis, enrolled in Coordinated Specialty Care at the Psychosis Education, Assessment, Care and Empowerment (PEACE) clinic and Psychosis Evaluation and Recovery Center (PERC).
  3. For clinician feasibility and acceptability measurement at intervention sites: Clinicians working at PEACE and PERC where the intervention will be piloted.
  4. For clinician implementation facilitator and barrier assessment at other Connection LHS sites to assess for scalability: Clinicians in Connection LHS who work at sites other than PEACE and PERC.Participants must sign the informed consent form

Exclusion Criteria:

  1. For intervention trial and patient feasibility and acceptability measurement: Expectation of leaving coordinated specialty care programing within 6 months (which will exclude all of the PI's patient panel) and/or intellectual disability of sufficient degree that the patient's primary psychiatrist expects to compromise capacity to consent to this research and/or psychosis secondary to another medical condition (which may not share the same motivational features that are otherwise understood about the primary psychiatric conditions with psychosis).
  2. For clinician feasibility and acceptability measurement at intervention sites: Study investigators who work at these clinics will be excluded from participation in the feasibility and acceptability study component given their role in the trial planning and execution.
  3. For clinician implementation facilitator and barrier assessment at other Connection LHS sites to assess for scalability: none.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Ikke-randomisert
  • Intervensjonsmodell: Enkeltgruppeoppdrag
  • Masking: Ingen (Open Label)

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Acceptability of intervention measure (AIM)
Tidsramme: Change at 8 months

The AIM is a 4-item scale measuring acceptability. Each item is scored 1-5 with 5 indicating greater acceptability. Minimum score is 4; maximum is 20.

Change at 8 months
Acceptability of intervention measure (AIM)
Tidsramme: Change at 6 months

The AIM is a 4-item scale measuring acceptability. Each item is scored 1-5 with 5 indicating greater acceptability. Minimum score is 4; maximum is 20.

Change at 6 months
Acceptability of intervention measure (AIM)
Tidsramme: Change at 4 months

The AIM is a 4-item scale measuring acceptability. Each item is scored 1-5 with 5 indicating greater acceptability. Minimum score is 4; maximum is 20.

Change at 4 months
Feasibility of intervention measure (FIM)
Tidsramme: Change at 8 months

The FIM is a 4-item scale measuring feasibility. Each item is scored 1-5 with 5 indicating greater feasibility. Minimum score is 4; maximum is 20.

Change at 8 months
Feasibility of intervention measure (FIM)
Tidsramme: Change at 6 months

The FIM is a 4-item scale measuring feasibility. Each item is scored 1-5 with 5 indicating greater feasibility. Minimum score is 4; maximum is 20.

Change at 6 months
Feasibility of intervention measure (FIM)
Tidsramme: Change at 4 months

The FIM is a 4-item scale measuring feasibility. Each item is scored 1-5 with 5 indicating greater feasibility. Minimum score is 4; maximum is 20.

Change at 4 months

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Implementation Survey Response
Tidsramme: Change at 8 months

Implementation survey. Results will be used to optimize intervention from implementation perspective.

Change at 8 months
Implementation Survey Response
Tidsramme: Change at 6 months

Implementation survey. Results will be used to optimize intervention from implementation perspective.

Change at 6 months
Implementation Survey Response
Tidsramme: Change at 4 months

Implementation survey. Results will be used to optimize intervention from implementation perspective.

Change at 4 months
Motivation Survey Response
Tidsramme: Change at 8 months

Motivation survey. Results will be used to optimize intervention from motivation perspective.

Change at 8 months
Motivation Survey Response
Tidsramme: Change at 6 months

Motivation survey. Results will be used to optimize intervention from motivation perspective.

Change at 6 months
Motivation Survey Response
Tidsramme: Change at 4 months

Motivation survey. Results will be used to optimize intervention from motivation perspective.

Change at 4 months
Ethical Concern Survey Response
Tidsramme: Change at 8 months

Ethical concern survey. Results will be used to optimize intervention from ethical acceptability perspective.

Change at 8 months
Ethical Concern Survey Response
Tidsramme: Change at 6 months

Ethical concern survey. Results will be used to optimize intervention from ethical acceptability perspective.

Change at 6 months
Ethical Concern Survey Response
Tidsramme: Change at 4 months

Ethical concern survey. Results will be used to optimize intervention from ethical acceptability perspective.

Change at 4 months

Andre resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
attrition
Tidsramme: Change at 8 months

rate of attrition

Change at 8 months
attrition
Tidsramme: Change at 6 months

rate of attrition

Change at 6 months
attrition
Tidsramme: Change at 4 months

rate of attrition

Change at 4 months
psychotic symptomology
Tidsramme: Change at 8 months

Compass-10. The Compass-10 is a self-report scale that measures multiple symptoms associated with psychosis, including mood symptoms. It consists of 10-items, each scored 0-6 with a minimum score of 0 and a maximum of 60. A higher score indicates greater symptomology.

Change at 8 months
psychotic symptomology
Tidsramme: Change at 6 months

Compass-10. The Compass-10 is a self-report scale that measures multiple symptoms associated with psychosis, including mood symptoms. It consists of 10-items, each scored 0-6 with a minimum score of 0 and a maximum of 60. A higher score indicates greater symptomology.

Change at 6 months
psychotic symptomology
Tidsramme: Change at 4 months

Compass-10. The Compass-10 is a self-report scale that measures multiple symptoms associated with psychosis, including mood symptoms. It consists of 10-items, each scored 0-6 with a minimum score of 0 and a maximum of 60. A higher score indicates greater symptomology.

Change at 4 months
psychotic symptomology
Tidsramme: Change at 8 months

modified-Colorado Symptom Index. The modified-Colorado Symptom Index is a 14-item, clinician-rated scale with items ranked 0-4. Total minimum score = 0. Total maximum score = 56. A higher score indicates greater symptomology.

Change at 8 months
psychotic symptomology
Tidsramme: Change at 6 months

modified-Colorado Symptom Index. The modified-Colorado Symptom Index is a 14-item, clinician-rated scale with items ranked 0-4. Total minimum score = 0. Total maximum score = 56. A higher score indicates greater symptomology.

Change at 6 months
psychotic symptomology
Tidsramme: Change at 4 months

modified-Colorado Symptom Index. The modified-Colorado Symptom Index is a 14-item, clinician-rated scale with items ranked 0-4. Total minimum score = 0. Total maximum score = 56. A higher score indicates greater symptomology.

Change at 4 months
depression
Tidsramme: Change at 8 months

abbreviated version of the Beck Depression Inventory-II (BDI-II) that has been previously validated (scale, min=0, max=21, higher mean score indicates more severe depressive symptomology)

Change at 8 months
depression
Tidsramme: Change at 6 months

abbreviated version of the Beck Depression Inventory-II (BDI-II) that has been previously validated (scale, min=0, max=21, higher mean score indicates more severe depressive symptomology)

Change at 6 months
depression
Tidsramme: Change at 4 months

abbreviated version of the Beck Depression Inventory-II (BDI-II) that has been previously validated (scale, min=0, max=21, higher mean score indicates more severe depressive symptomology)

Change at 4 months
quality of life
Tidsramme: Change at 8 months

4-item version of the Lehman Quality of Life Scale (min = 4, max =28, higher score is improved quality of life)

Change at 8 months
quality of life
Tidsramme: Change at 6 months

4-item version of the Lehman Quality of Life Scale (min = 4, max =28, higher score is improved quality of life)

Change at 6 months
quality of life
Tidsramme: Change at 4 months

4-item version of the Lehman Quality of Life Scale (min = 4, max =28, higher score is improved quality of life)

Change at 4 months
recovery
Tidsramme: Change at 8 months

5-item version of the Questionnaire about the Process of Recovery (scale, min=5, max=25, higher mean indicates more perceived recovery)

Change at 8 months
recovery
Tidsramme: Change at 6 months

5-item version of the Questionnaire about the Process of Recovery (scale, min=5, max=25, higher mean indicates more perceived recovery)

Change at 6 months
recovery
Tidsramme: Change at 4 months

5-item version of the Questionnaire about the Process of Recovery (scale, min=5, max=25, higher mean indicates more perceived recovery)

Change at 4 months
treatment motivation (intrinsic versus extrinsic)
Tidsramme: Change at 8 months

Treatment Motivation Questionnaire-Revised (TMQ-R). The Treatment Motivation Questionnaire-Revised is a 25-item self-assessment survey that assesses several elements of treatment motivation, each ranked 1-5. It is not a single scale that results in an overall score. Some items suggest greatest motivation at a 5 and least at a 1, but others suggest greatest motivation at a 1 and least at a 5.

Change at 8 months
treatment motivation (intrinsic versus extrinsic)
Tidsramme: Change at 6 months

Treatment Motivation Questionnaire-Revised (TMQ-R). The Treatment Motivation Questionnaire-Revised is a 25-item self-assessment survey that assesses several elements of treatment motivation, each ranked 1-5. It is not a single scale that results in an overall score. Some items suggest greatest motivation at a 5 and least at a 1, but others suggest greatest motivation at a 1 and least at a 5.

Change at 6 months
treatment motivation (intrinsic versus extrinsic)
Tidsramme: Change at 4 months

Treatment Motivation Questionnaire-Revised (TMQ-R). The Treatment Motivation Questionnaire-Revised is a 25-item self-assessment survey that assesses several elements of treatment motivation, each ranked 1-5. It is not a single scale that results in an overall score. Some items suggest greatest motivation at a 5 and least at a 1, but others suggest greatest motivation at a 1 and least at a 5.

Change at 4 months
Perceived coercion
Tidsramme: Change at 8 months

Modified version of the MacArthur Admission Experience Survey (AES). The MacArthur AES was developed as a self-assessment for assessing coercion and pressure during inpatient admission. It was previously modified for assisted outpatient treatment. We have modified it further to a 13-item scale for outpatient treatment generally. Each item is assessed as true or false, where true suggests great perception of pressure or coercion on some items, but less on others.

Change at 8 months
Perceived coercion
Tidsramme: Change at 6 months

Modified version of the MacArthur Admission Experience Survey (AES). The MacArthur AES was developed as a self-assessment for assessing coercion and pressure during inpatient admission. It was previously modified for assisted outpatient treatment. We have modified it further to a 13-item scale for outpatient treatment generally. Each item is assessed as true or false, where true suggests great perception of pressure or coercion on some items, but less on others.

Change at 6 months
Perceived coercion
Tidsramme: Change at 4 months

Modified version of the MacArthur Admission Experience Survey (AES). The MacArthur AES was developed as a self-assessment for assessing coercion and pressure during inpatient admission. It was previously modified for assisted outpatient treatment. We have modified it further to a 13-item scale for outpatient treatment generally. Each item is assessed as true or false, where true suggests great perception of pressure or coercion on some items, but less on others.

Change at 4 months
attendance rate
Tidsramme: Change over 8 months

number of appointments attended in a given period divided by number of appointments scheduled

Change over 8 months
attendance rate
Tidsramme: Change at 6 months

number of appointments attended in a given period divided by number of appointments scheduled

Change at 6 months
attendance rate
Tidsramme: Change at 4 months

number of appointments attended in a given period divided by number of appointments scheduled

Change at 4 months

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Samarbeidspartnere

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. februar 2025

Primær fullføring (Faktiske)

18. desember 2025

Studiet fullført (Antatt)

31. desember 2026

Datoer for studieregistrering

Først innsendt

20. juni 2023

Først innsendt som oppfylte QC-kriteriene

28. juli 2023

Først lagt ut (Faktiske)

1. august 2023

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

6. oktober 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

1. oktober 2026

Sist bekreftet

1. oktober 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • 2023-03

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .